Patrick Vallance has been instrumental in turning around international sentiment towards the UK as a life sciences destination, says ABPI's Richard Torbett
Since the UK-US deal was announced in December, there have been 13 pharmaceutical investment commitments across the UK, totalling £1.4 billion in inward investment